Arlington Trust’s NeoGenomics NEO Stock Holding History

Arlington Trust’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.98K	Hold	108	–	–	﹤0.01%	770
2026 Q2	$1.58K	Hold	108	–	–	﹤0.01%	704
2026 Q1	$801	Hold	108	–	–	﹤0.01%	736
2025 Q4	$1.27K	Hold	108	–	–	﹤0.01%	419
2025 Q3	$834	Hold	108	–	–	﹤0.01%	575
2025 Q2	$789	Hold	108	–	–	﹤0.01%	607
2025 Q1	$1.02K	Hold	108	–	–	﹤0.01%	602
2024 Q4	$1.78K	Hold	108	–	–	﹤0.01%	533
2024 Q3	$1.59K	Hold	108	–	–	﹤0.01%	533
2024 Q2	$1.5K	Hold	108	–	–	﹤0.01%	515
2024 Q1	$1.7K	Hold	108	–	–	﹤0.01%	462
2023 Q4	$1.75K	Buy	+108	New	+$1.77K	﹤0.01%	655

Other funds holding NEO

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Arlington Trust's NEO Position: Q3 2026 in Review

Arlington Trust held its NeoGenomics (NEO) position steady in Q3 2026 at 108 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #770.

Arlington Trust first reported a position in NEO in Q4 2023 and has held it in 12 quarters since. 47 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

Arlington Trust held 108 shares of NeoGenomics worth $1.98K as of Q3 2026.
Arlington Trust left its NeoGenomics share count unchanged in Q3 2026.
NeoGenomics made up ﹤0.01% of Arlington Trust's portfolio in Q3 2026, its #770 holding.
Arlington Trust first reported a position in NeoGenomics in Q4 2023 and has held it in 12 quarters since.
47 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.